Company Financials

Neurocrine Biosciences, Inc. Financials

United States dollar

business Neurocrine Biosciences, Inc. Company Profile

Main Stock Listing

NASDAQ: NBIX

Market Capitalization $14.02 Billion as of Jan. 1, 2026

Market Cap History

Valuations Metrics as of Jan. 3, 2026

Trailing PE 33.44
Forward PE 15.23
Price to Sales TTM $5.19
Price to Book MRQ $4.64
Enterprise to Revenue 5.04
Enterprise to EBITDA 23.70

Financial Reports as of Sep. 30, 2025

Financials

Fiscal Year Ends 2024-12-31
Most Recent Quarter 2025-09-30
Profit Margin 15.95%
Operating Margin 30.10%
Return on Assets TTM 8.66%
Return on Equity TTM 14.96%

Income Statement

Revenue TTM $2,682,700,032
Revenue per Share TTM $26.98
Quarterly Revenue Growth 27.80%
Gross Profit TTM $1,695,800,064
EBITDA $502,300,000
Net Income to Common TTM $428,000,000
Diluted EPS TTM $4.18
Quarterly Earnings Growth YoY 61.40%

Balance Sheet

Total Cash MRQ $1,114,800,000
Total Cash per Share MRQ $11.18
Total Debt MRQ $
Total Debt to Equity MRQ 15.97
Current Ratio MRQ 3.38
Book Value per Share MRQ $30.13

Cash Flow

Operating Cash Flow TTM $636,800,000
Levered Free Cash Flow TTM $346,187,488

NBIX Stock Info as of Jan. 3, 2026

Stock Statistics

Shares Outstanding 99,700,000
Float Shares 98,532,162
Avg 10 Volume 838,310
Avg 30 Volume None
Shares Short 3,939,195
Short Ratio 4.17
Short % of Shares 5.26%
% Held by Insiders 1.02%
% Held by Institutions 101.04%

Stock Price Summary

Beta 0.27
Fifty Two Week Low $84.23
Fifty Two Week High $160.18
Fifty Two Week Change 2.67%
Day 50 MA $146.78
Day 200 MA $130.90

Dividends and Splits

Forward Annual Dividend Rate $
Forward Annual Dividend Yield %
Trailing Annual Dividend Rate $0.00
Trailing Annual Dividend Yield 0.00%
Payout Ratio 0.00%
Dividend Date
Ex Dividend Date 1995-12-29
Last Split Factor
Last Split Date